Discuss This Drug

Mirikizumab Inj 300 mg/15 mL Vial Reform

CHEBI:CHEBI_747624

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

dosage_form
INJECTION
product_type
DRUG FOR FURTHER PROCESSING
marketing_category
DRUG FOR FURTHER PROCESSING
marketing_start_date
20231026
package_marketing_start_date
26-OCT-23
labeler_name
BSP Pharmaceuticals
generic_name
Mirikizumab Inj 300 mg/15 mL Vial Reform
product_ndc
43624-026
spl_id
25b7b781-a203-3864-e063-6394a90a1274
active_ingredient_name
MIRIKIZUMAB
active_ingredient_strength
300 ug/15mL
package_ndc
43624-026-01
package_description
121 VIAL, SINGLE-DOSE in 1 TRAY (43624-026-01) / 15 mL in 1 VIAL, SINGLE-DOSE
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class